Mutations in HIV-1gagandpolCompensate for the Loss of Viral Fitness Caused by a Highly Mutated Protease

HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge

(2012) Martin Obermeier et al.   INTERVIROLOGY

Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity

(2012) Noortje M van Maarseveen et al.   Retrovirology

Transmitted Antiretroviral Drug Resistance in Individuals with Newly Diagnosed HIV Infection: South Carolina 2005–2009

(2011) Eren Youmans et al.   SOUTHERN MEDICAL JOURNAL

HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland

(2010) Erika Castro et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Antiretroviral Treatment of Adult HIV Infection

(2010) Melanie A. Thompson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia

(2010) Dace Balode et al.   JOURNAL OF MEDICAL VIROLOGY

Reduced Fitness in Cell Culture of HIV-1 with Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Mutations Correlates with Relative Levels of Reverse Transcriptase Content and RNase H Activity in Virions

(2010) J. Wang et al.   JOURNAL OF VIROLOGY

Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time

(2010) Dineke Frentz et al.   PLoS One

Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009

(2010) Vivek Jain et al.   PLoS One

Maintaining Reduced Viral Fitness and CD4 Response in HIV‐Infected Patients with Viremia Receiving a Boosted Protease Inhibitor

(2009) Philip Grant et al.   CLINICAL INFECTIOUS DISEASES

Molecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor Darunavir

(2009) K. G. Saskova et al.   JOURNAL OF VIROLOGY

Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody

(2009) Julien Lescar et al.   PROTEIN SCIENCE

Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss

(2009) Elisabeth Dam et al.   PLoS Pathogens

Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies

(2008) Vanda Bartoňová et al.   ANTIVIRAL RESEARCH

Ninety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap Region

(2008) M. Kozisek et al.   JOURNAL OF VIROLOGY

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE

Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir

(2008) Klára Grantz Šašková et al.   PROTEIN SCIENCE

Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings

(2008) K. E. Little et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Drug-associated changes in amino acid residues in Gag p2, p7NC, and p6Gag/p6Pol in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response

(2008) Sarah K. Ho et al.   VIROLOGY